Tag: Organon

Granules India gains FDA approval for Losartan-Hydrochlorothiazide Tablets

businessnewstoday- September 30, 2023

Granules India Limited proudly announced today that the United States Food & Drug Administration (US FDA) has granted its Abbreviated New Drug Application (ANDA) for ... Read More

Organon, Samsung Bioepis launch HUMIRA biosimilar HADLIMA in US

businessnewstoday- July 1, 2023

Organon & Co. and Samsung Bioepis revealed that HADLIMA (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab), is now accessible to patients in the United States. This ... Read More